Alpha1-antitrypsin deficiency and asthma: The continuing search for the relationship

Postgraduate Medicine

Volumn 101, Issue 4, 1997, Pages

  Pina, Joseph S ^a   Horan, Mary P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ELASTIN; PREDNISONE; SALBUTAMOL; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ASTHMA; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; ENZYME REPLACEMENT; GENOTYPE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; PROGNOSIS; REVIEW;

EID: 0030948253     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1997.04.200     Document Type: Review

References (19)

1. Blank CA, Brantly M. Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency. Ann Allergy 1994; 72(2):105-20 [Erratum, Ann Allergy 1994;72(4):305]
2. 1-antitrypsin deficiency - diagnosis, treatment, and control: identification of patients. Lung 1990;168(Suppl):543-51
3. 1-antitrypsin deficiency: pathogenesis and treatment. Hosp Pract(Off Ed) 1991;26(2):81-94
4. Weiss EB, Stein M, eds. Bronchial asthma: mechanisms and therapeutics. 3d ed. Boston: Little, Brown, 1993
5. Silverman EK, Miletich JP, Pierce JA, et al. Alpha-1-antitrypsin deficiency: high prevalence in the St Louis area determined by direct population screening. Am Rev Respir Dis 1989;140(4):961-6
6. Silverman EK, Pierce JA, Province MA, et al. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates. Ann Intern Med 1989;111(12):982-91
7. 1-antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132-40
8. 1-proteinase inhibitor. Am J Physiol 1994; 266(6 Pt 1):L593-611 [Erratum, Am J Physiol 1995;268(1 Pt 1):section L following table of contents and 1995;268(6 Pt 3): section L following table of contents]
9. Townley RG, Southard JG, Radford P, et al. Association of MS Pi phenotype with airway hyperresponsiveness. Chest 1990;98(3):594-9
10. Gaillard MC, Kilroe-Smith TA, Nogueira C, et al. Alpha-1-protease inhibitor in bronchial asthma: phenotypes and biochemical characteristics. Am Rev Respir Dis 1992;145(6):1311-5
11. 1-antitrypsin deficiency, Pi Z. Acta Med Scand 1978;204(5):345-51
12. Janus ED, Phillips NT, Carrell RW. Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet 1985;1(8421):152-4
13. Hyde JS, Werner P, Kumar CM, et al. Protease inhibitor variants in children and young adults with chronic asthma. Ann Allergy 1979;43(1):8-13
14. Holden DA, Págliaccio L, Goormastic M, et al. Asthmatic presentation of alpha 1-antitrypsin (A1AT) deficiency: a clinical profile. (Abstr) Chest 1991;100(2):43S
15. American Thoracic Society. Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency. Am Rev Respir Dis 1989;140(5): 1494-7
16. Brantly ML, Paul LD, Miller BH, et al. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988;138(2):327-36
17. Cherniack NS. Chronic obstructive pulmonary disease. Philadelphia: Saunders, 1991
18. 1-antitrypsin deficiency: results of a survey. Cleve Clin J Med 1994;61(6):461-7
19. Wewers MD, Casolaro MA, Sellers SE, et al. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987;316(17):1055-62